High-normal serum uric acid increases risk of early progressive renal function loss in type 1 diabetes: results of a 6-year follow-up

LH Ficociello, ET Rosolowsky, MA Niewczas… - Diabetes …, 2010 - Am Diabetes Assoc
OBJECTIVE We previously described a cross-sectional association between serum uric acid
and reduced glomerular filtration rate (GFR) in nonproteinuric patients with type 1 diabetes. …

High-normal serum uric acid is associated with impaired glomerular filtration rate in nonproteinuric patients with type 1 diabetes

ET Rosolowsky, LH Ficociello, NJ Maselli… - Clinical Journal of the …, 2008 - journals.lww.com
Background and objectives: Early renal function decline begins before the onset of
proteinuria in patients with type 1 diabetes. The association of elevated serum uric acid with …

Serum concentrations of markers of TNFα and Fas-mediated pathways and renal function in nonproteinuric patients with type 1 diabetes

…, AC Johnson, W Walker, ET Rosolowsky… - Clinical Journal of the …, 2009 - journals.lww.com
… For continuous variables and frequencies, t-tests and χ 2 tests with alpha = 0.05 were used,
respectively. Analyses in Tables 2 and 3 and Figure 1 were ANOVA for unbalanced design …

Risk for ESRD in type 1 diabetes remains high despite renoprotection

ET Rosolowsky, J Skupien, AM Smiles… - Journal of the …, 2011 - journals.lww.com
Historically, patients with type 1 diabetes and macroalbuminuria had high competing risks:
cardiovascular death or renal failure. Here, we assessed these risks in patients receiving …

[HTML][HTML] Incidence and risk factors for hypoglycemia during fetal-to-neonatal transition in premature infants

NA Mitchell, C Grimbly, ET Rosolowsky… - Frontiers in …, 2020 - frontiersin.org
Objective: To determine the incidence and risk factors associated with neonatal hypoglycemia
in the premature population <33 weeks' gestation. Methods: This was a secondary …

Between hyperfiltration and impairment: demystifying early renal functional changes in diabetic nephropathy

ET Rosolowsky, MA Niewczas, LH Ficociello… - Diabetes research and …, 2008 - Elsevier
Renal functional changes in diabetic nephropathy conventionally have been linked to
progression of urinary albumin excretion. This paradigm was based on historic evidence noting …

Growth hormone treatment of Canadian children: results from the GeNeSIS phase IV prospective observational study

…, S Lawrence, E Cummings, ET Rosolowsky… - … Open Access Journal, 2018 - cmajopen.ca
Background: Country-specific data on outcomes of treatment with recombinant human growth
hormone are lacking. We present such data for children treated with growth hormone in …

Canadian Cystic Fibrosis–related Diabetes Clinical Practice Survey: Analysis of Current Practices and Gaps in Clinical Care

…, S Tagougui, A Jober, M Pohl, ET Rosolowsky… - Canadian Journal of …, 2023 - Elsevier
Objectives Our aim in this study was to identify challenges and gaps in Canadian practices
in screening, diagnosis, and treatment of cystic fibrosis–related diabetes (CFRD), with the …

[HTML][HTML] 46, XY disorder of sex development due to 17-beta hydroxysteroid dehydrogenase type 3 deficiency: a plea for timely genetic testing

…, P Metcalfe, MM Jetha, ET Rosolowsky - International Journal of …, 2016 - Springer
Background 17β-hydroxysteroid dehydrogenase type 3 (17βHSD3) deficiency is a rare cause
of disorder of sex development (DSD) due to impaired conversion of androstenedione to …

Use of glucagon‐like peptide‐1 receptor agonists for pediatric patients with obesity and diabetes: The providers' perspectives

…, KN Tonyushkina, ET Rosolowsky… - Pediatric …, 2021 - Wiley Online Library
Background Glucagon‐like peptide‐1 receptor agonists (GLP‐1RA) have been widely used
in adults with Type 2 diabetes (T2D) and obesity. We sought to evaluate the experience of …